Health-Related Quality of Life and work productivity improvements with topical delgocitinib vs oral alitretinoin in Chronic Hand Eczema: phase 3 DELTA FORCE results (EADV 2026) - Aug 6, 2026 - Abstract #P1608; AS-1951; Pres time: Sep 30, 2026; Location: ePoster Area; P3 | "Furthermore, work productivity and daily activity impairment improved to a larger extent. These findings indicate that delgocitinib cream may serve as a valuable topical treatment option for patients with moderate to severe CHE in routine care, prior to the need for systemic therapy."
Clinical • HEOR • P3 data • Contact Dermatitis • Dermatology • Immunology
|
|
Andrea Bauer; Timo Buhl; Richard Woolf; James Greig; Jenny M. Norlin; Henrik Thoning; Ana Maria Giménez-Arnau
|